Truist Financial’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-6,847
| Closed | -$239K | – | 2571 |
|
|
2024
Q4 | $239K | Sell |
6,847
-501
| -7% | -$17.5K | ﹤0.01% | 2264 |
|
|
2024
Q3 | $294K | Sell |
7,348
-655
| -8% | -$26.2K | ﹤0.01% | 2125 |
|
|
2024
Q2 | $381K | Sell |
8,003
-1,496
| -16% | -$71.3K | ﹤0.01% | 2131 |
|
|
2024
Q1 | $412K | Sell |
9,499
-466
| -5% | -$20.2K | ﹤0.01% | 2093 |
|
|
2023
Q4 | $504K | Buy |
+9,965
| New | +$504K | ﹤0.01% | 1956 |
|
|
2022
Q4 | – | Sell |
-6,420
| Closed | -$284K | – | 2621 |
|
|
2022
Q3 | $284K | Sell |
6,420
-15,944
| -71% | -$705K | ﹤0.01% | 2103 |
|
|
2022
Q2 | $828K | Sell |
22,364
-8,906
| -28% | -$330K | ﹤0.01% | 1638 |
|
|
2022
Q1 | $1.16M | Buy |
31,270
+333
| +1% | +$12.3K | ﹤0.01% | 1554 |
|
|
2021
Q4 | $941K | Sell |
30,937
-40
| -0.1% | -$1.22K | ﹤0.01% | 1652 |
|
|
2021
Q3 | $1.04M | Buy |
30,977
+5,876
| +23% | +$197K | ﹤0.01% | 1568 |
|
|
2021
Q2 | $1M | Buy |
25,101
+3,437
| +16% | +$137K | ﹤0.01% | 1643 |
|
|
2021
Q1 | $974K | Buy |
21,664
+10,408
| +92% | +$468K | ﹤0.01% | 1604 |
|
|
2020
Q4 | $636K | Sell |
11,256
-207
| -2% | -$11.7K | ﹤0.01% | 1725 |
|
|
2020
Q3 | $545K | Sell |
11,463
-392
| -3% | -$18.6K | ﹤0.01% | 1669 |
|
|
2020
Q2 | $698K | Buy |
11,855
+183
| +2% | +$10.8K | ﹤0.01% | 1438 |
|
|
2020
Q1 | $551K | Sell |
11,672
-1,609
| -12% | -$76K | ﹤0.01% | 1500 |
|
|
2019
Q4 | $802K | Buy |
+13,281
| New | +$802K | ﹤0.01% | 1544 |
|